dr. weber on combination strategies for braf-mutant melanoma
Published 7 years ago • 118 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
3:19
future combination strategies for braf-mutant melanoma
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
1:44
dr. jeffrey weber on optimal therapy sequences in advanced melanoma
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
1:16
dr. weber on emerging immunotherapy combinations in melanoma
-
7:01
dual-targeted therapy for braf-mutant melanoma
-
2:54
emerging treatment strategies for advanced braf melanoma
-
1:46
dr. weber on selecting immunotherapy for patients with melanoma
-
1:15
dr. weber on nivolumab in the adjuvant setting for melanoma
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
5:31
treating braf-mutated metastatic melanoma
-
1:42
dr. weber on biomarker data from checkmate-238 for melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
8:40
melanoma: braf/mek targeted therapy
-
6:42
combination strategies in melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
1:29
dr. weber on future treatment approaches for patients with melanoma
-
9:49
melanoma: nuances of braf/mek combinations in the front line